6-K/A Filing

RENALYTIX PLC CIK: 1811115

Filing Information

Form Type	6-K/A
Accession Number	`0000950170-22-006745`
Period End Date	20211231
Filing Date	20220429
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	rnlx-20220429_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 86 Cash Flow Statement 88 Stockholders Equity 31

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Common stock par or stated value per share	`CommonStockParOrStatedValuePerShare`	0.00	GBP	Point-in-time
Common stock par or stated value per share	`CommonStockParOrStatedValuePerShare`	0.00	GBP	Point-in-time
Common stock shares authorized	`CommonStockSharesAuthorized`	76.68M	shares	Point-in-time
Common stock shares authorized	`CommonStockSharesAuthorized`	76.68M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$65.13M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$39.93M	USD	Point-in-time
Common stock shares issued	`CommonStockSharesIssued`	72.31M	shares	Point-in-time
Common stock shares issued	`CommonStockSharesIssued`	72.20M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$823.00K	USD	Point-in-time
Common stock shares outstanding	`CommonStockSharesOutstanding`	72.20M	shares	Point-in-time
Common stock shares outstanding	`CommonStockSharesOutstanding`	72.31M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$594.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$993.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.55M	USD	Point-in-time
Note receivable from Kantaro	`NotesReceivableRelatedPartiesCurrent`	$75.00K	USD	Point-in-time
Note receivable from Kantaro	`NotesReceivableRelatedPartiesCurrent`	$75.00K	USD	Point-in-time
Receivable from affiliates	`DueFromAffiliateCurrent`	$1.00K	USD	Point-in-time
Receivable from affiliates	`DueFromAffiliateCurrent`	$35.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$44.41M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$66.79M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.49M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.88M	USD	Point-in-time
Investment in VericiDx	`InvestmentsInAndAdvancesToAffiliatesAtFairValue`	$7.03M	USD	Point-in-time
Investment in VericiDx	`InvestmentsInAndAdvancesToAffiliatesAtFairValue`	$9.29M	USD	Point-in-time
Investment in Kantaro	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	-	USD	Point-in-time
Investment in Kantaro	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$37.00K	USD	Point-in-time
Total assets	`Assets`	$78.58M	USD	Point-in-time
Total assets	`Assets`	$54.36M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.38M	USD	Point-in-time
Accounts payable-related party	`AccountsPayableRelatedPartiesCurrent`	$1.01M	USD	Point-in-time
Accounts payable-related party	`AccountsPayableRelatedPartiesCurrent`	$361.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$4.53M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$4.60M	USD	Point-in-time
Accrued expensesrelated party	`AccruedExpensesRelatedPartyCurrent`	$224.00K	USD	Point-in-time
Accrued expensesrelated party	`AccruedExpensesRelatedPartyCurrent`	$1.34M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$122.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$67.00K	USD	Point-in-time
Payable to affiliatecurrent	`DueToAffiliateCurrent`	$350.00K	USD	Point-in-time
Payable to affiliatecurrent	`DueToAffiliateCurrent`	$219.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.06M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$15.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$53.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$7.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.56M	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, 0.0025 par value per share: 76,681,831 shares authorized; 72,308,930 and 72,197,286 shares issued and outstanding at December 31, 2021 and June 30, 2021, respectively	`CommonStockValue`	$220.00K	USD	Point-in-time
Ordinary shares, 0.0025 par value per share: 76,681,831 shares authorized; 72,308,930 and 72,197,286 shares issued and outstanding at December 31, 2021 and June 30, 2021, respectively	`CommonStockValue`	$220.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$152.66M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$150.41M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$8.28M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$5.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-87.44M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-112.87M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$59.97M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$71.46M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$45.80M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$15.91M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$86.90M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$87.12M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$54.36M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$78.58M	USD	Point-in-time

Income Statement 86 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$400.00K	USD	2 Qtrs
Revenue	`Revenues`	$400.00K	USD	1 Quarter
Revenue	`Revenues`	$845.00K	USD	1 Quarter
Revenue	`Revenues`	$1.33M	USD	2 Qtrs
Cost of revenue	`CostOfRevenue`	$257.00K	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$257.00K	USD	2 Qtrs
Cost of revenue	`CostOfRevenue`	$492.00K	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$719.00K	USD	2 Qtrs
Gross profit	`GrossProfit`	$143.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$143.00K	USD	2 Qtrs
Gross profit	`GrossProfit`	$353.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$608.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$4.13M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$4.21M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$8.13M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.46M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$18.20M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$10.71M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.59M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$10.07M	USD	1 Quarter
Performance of contract liability to affiliate	`PerformanceOfContractLiabilityToAffiliate`	$301.00K	USD	1 Quarter
Performance of contract liability to affiliate	`PerformanceOfContractLiabilityToAffiliate`	$70.00K	USD	1 Quarter
Performance of contract liability to affiliate	`PerformanceOfContractLiabilityToAffiliate`	$759.00K	USD	2 Qtrs
Performance of contract liability to affiliate	`PerformanceOfContractLiabilityToAffiliate`	$131.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$26.20M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$14.13M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.76M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$14.16M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-8.61M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-14.02M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-13.78M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-25.60M	USD	2 Qtrs
Equity in net earnings (losses) of affiliate	`IncomeLossFromEquityMethodInvestments`	$-105.00K	USD	1 Quarter
Equity in net earnings (losses) of affiliate	`IncomeLossFromEquityMethodInvestments`	$-221.00K	USD	2 Qtrs
Equity in net earnings (losses) of affiliate	`IncomeLossFromEquityMethodInvestments`	$37.00K	USD	2 Qtrs
Equity in net earnings (losses) of affiliate	`IncomeLossFromEquityMethodInvestments`	$37.00K	USD	1 Quarter
Foreign currency /gain (loss)	`ForeignCurrencyTransactionGainLossBeforeTax`	$-163.00K	USD	1 Quarter
Foreign currency /gain (loss)	`ForeignCurrencyTransactionGainLossBeforeTax`	$-7.69M	USD	2 Qtrs
Foreign currency /gain (loss)	`ForeignCurrencyTransactionGainLossBeforeTax`	$2.14M	USD	2 Qtrs
Foreign currency /gain (loss)	`ForeignCurrencyTransactionGainLossBeforeTax`	$-5.54M	USD	1 Quarter
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$5.02M	USD	1 Quarter
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$1.41M	USD	1 Quarter
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$2.02M	USD	2 Qtrs
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$5.02M	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$115.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$167.00K	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$12.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-9.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-25.43M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-16.74M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-15.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.61M	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-611.00K	USD	2 Qtrs
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-218.00K	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Net loss attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.13M	USD	2 Qtrs
Net loss attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.91M	USD	1 Quarter
Net loss attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-25.43M	USD	2 Qtrs
Net loss attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-15.32M	USD	1 Quarter
Foreign exchange translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$97.00K	USD	1 Quarter
Foreign exchange translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-2.49M	USD	2 Qtrs
Foreign exchange translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$8.34M	USD	2 Qtrs
Foreign exchange translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$6.09M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.04M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-15.22M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-27.92M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-8.40M	USD	2 Qtrs
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-5.00K	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-72.00K	USD	2 Qtrs
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Comprehensive loss attributable to Renalytix	`ComprehensiveIncomeNetOfTax`	$-8.33M	USD	2 Qtrs
Comprehensive loss attributable to Renalytix	`ComprehensiveIncomeNetOfTax`	$-15.22M	USD	1 Quarter
Comprehensive loss attributable to Renalytix	`ComprehensiveIncomeNetOfTax`	$-27.92M	USD	2 Qtrs
Comprehensive loss attributable to Renalytix	`ComprehensiveIncomeNetOfTax`	$-3.04M	USD	1 Quarter
Net loss per ordinary sharebasic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.21	USD	1 Quarter
Net loss per ordinary sharebasic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	2 Qtrs
Net loss per ordinary sharebasic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	2 Qtrs
Net loss per ordinary sharebasic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.12	USD	1 Quarter
Weighted average ordinary sharesbasic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	72.03M	shares	1 Quarter
Weighted average ordinary sharesbasic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	72.29M	shares	1 Quarter
Weighted average ordinary sharesbasic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	72.26M	shares	2 Qtrs
Weighted average ordinary sharesbasic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	70.93M	shares	2 Qtrs

Cash Flow Statement 88 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-9.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-25.43M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-16.74M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-15.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.61M	USD	1 Quarter
Gain on deconsolidation of VericiDx	`DeconsolidationGainOrLossAmount`	-	USD	2 Qtrs
Gain on deconsolidation of VericiDx	`DeconsolidationGainOrLossAmount`	$46.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$105.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$226.00K	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$1.94M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$1.03M	USD	2 Qtrs
Realized gain on short-term investments	`DebtAndEquitySecuritiesRealizedGainLoss`	$18.00K	USD	2 Qtrs
Realized gain on short-term investments	`DebtAndEquitySecuritiesRealizedGainLoss`	-	USD	2 Qtrs
Equity in (net earnings) losses in affiliate	`IncomeLossFromEquityMethodInvestments`	$-105.00K	USD	1 Quarter
Equity in (net earnings) losses in affiliate	`IncomeLossFromEquityMethodInvestments`	$-221.00K	USD	2 Qtrs
Equity in (net earnings) losses in affiliate	`IncomeLossFromEquityMethodInvestments`	$37.00K	USD	2 Qtrs
Equity in (net earnings) losses in affiliate	`IncomeLossFromEquityMethodInvestments`	$37.00K	USD	1 Quarter
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$5.02M	USD	1 Quarter
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$1.41M	USD	1 Quarter
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$2.02M	USD	2 Qtrs
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$5.02M	USD	2 Qtrs
Unrealized foreign exchange loss (gain)	`ForeignCurrencyTransactionGainLossUnrealized`	$-4.63M	USD	2 Qtrs
Unrealized foreign exchange loss (gain)	`ForeignCurrencyTransactionGainLossUnrealized`	$1.86M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$229.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$400.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.54M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.19M	USD	2 Qtrs
Related party receivable	`IncreaseDecreaseInDueFromRelatedParties`	$34.00K	USD	2 Qtrs
Related party receivable	`IncreaseDecreaseInDueFromRelatedParties`	$140.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-15.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$79.00K	USD	2 Qtrs
Accounts payable - related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$646.00K	USD	2 Qtrs
Accounts payable - related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	-	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.34M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-304.00K	USD	2 Qtrs
Accrued expensesrelated party	`IncreaseDecreaseInAccruedExpensesRelatedParty`	$282.00K	USD	2 Qtrs
Accrued expensesrelated party	`IncreaseDecreaseInAccruedExpensesRelatedParty`	$1.11M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-55.00K	USD	2 Qtrs
Payable to affiliate	`IncreaseDecreaseInDueToAffiliates`	$-760.00K	USD	2 Qtrs
Payable to affiliate	`IncreaseDecreaseInDueToAffiliates`	$-131.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-38.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$53.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.58M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-24.73M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$728.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$290.00K	USD	2 Qtrs
Software development costs	`PaymentsToDevelopSoftware`	$536.00K	USD	2 Qtrs
Software development costs	`PaymentsToDevelopSoftware`	$98.00K	USD	2 Qtrs
Proceeds from short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$1.00M	USD	2 Qtrs
Proceeds from short-term investments	`ProceedsFromSaleOfShortTermInvestments`	-	USD	2 Qtrs
Note receivablerelated party	`ProceedsFromNotesReceivableRelatedParty`	$-84.00K	USD	2 Qtrs
Note receivablerelated party	`ProceedsFromNotesReceivableRelatedParty`	-	USD	2 Qtrs
Decrease in cash (VericiDx deconsolidation)	`CashDivestedFromDeconsolidation`	$62.00K	USD	2 Qtrs
Decrease in cash (VericiDx deconsolidation)	`CashDivestedFromDeconsolidation`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-388.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-410.00K	USD	2 Qtrs
Gross proceeds from the issuance of ordinary shares, net of underwriting fees	`GrossProceedsFromTheIssuanceOfOrdinarySharesNetOfUnderwritingFees`	-	USD	2 Qtrs
Gross proceeds from the issuance of ordinary shares, net of underwriting fees	`GrossProceedsFromTheIssuanceOfOrdinarySharesNetOfUnderwritingFees`	$79.18M	USD	2 Qtrs
Payment of offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	2 Qtrs
Payment of offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	$2.31M	USD	2 Qtrs
Proceeds from the issuance of ordinary shares under employee share purchase plan	`ProceedsFromTheIssuanceOfOrdinarySharesUnderEmployeeSharePurchasePlan`	-	USD	2 Qtrs
Proceeds from the issuance of ordinary shares under employee share purchase plan	`ProceedsFromTheIssuanceOfOrdinarySharesUnderEmployeeSharePurchasePlan`	$120.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$197.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$317.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$76.88M	USD	2 Qtrs
Effect of exchange rate changes on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-395.00K	USD	2 Qtrs
Effect of exchange rate changes on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$3.35M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-25.20M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$61.24M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$65.13M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.29M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$39.93M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$74.53M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$65.13M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.29M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$39.93M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$74.53M	USD	Point-in-time
Deemed distribution of VericiDx ordinary shares	`DeemedDistributionOfOrdinarySharesNonCashTransaction`	-	USD	2 Qtrs
Deemed distribution of VericiDx ordinary shares	`DeemedDistributionOfOrdinarySharesNonCashTransaction`	$75.00K	USD	2 Qtrs
Conversion of distribution of VericiDx note receivable into VericiDx ordinary shares	`ConversionOfNotesReceivableIntoOrdinaryShares`	$2.56M	USD	2 Qtrs
Conversion of distribution of VericiDx note receivable into VericiDx ordinary shares	`ConversionOfNotesReceivableIntoOrdinaryShares`	-	USD	2 Qtrs
Software development costs in accounts payable and accrued expenses	`SoftwareDevelopmentCostsIncurredButNotPaid`	$77.00K	USD	2 Qtrs
Software development costs in accounts payable and accrued expenses	`SoftwareDevelopmentCostsIncurredButNotPaid`	-	USD	2 Qtrs
Purchase of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$126.00K	USD	2 Qtrs
Purchase of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$254.00K	USD	2 Qtrs

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$59.97M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$71.46M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$45.80M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$15.91M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$86.90M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$87.12M	USD	Point-in-time
VericiDx noncontrolling interest upon deconsolidation	`NoncontrollingInterestDecreaseFromDeconsolidation`	$2.30M	USD	1 Quarter
Shares issued under the employee share purchase plan (Value)	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$120.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$941.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$501.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$525.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$997.00K	USD	1 Quarter
Exercise of stock options (Value)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$111.00K	USD	1 Quarter
Exercise of stock options (Value)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$86.00K	USD	1 Quarter
Exercise of stock options (Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	100,724.00	shares	2 Qtrs
Currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$6.08M	USD	1 Quarter
Currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.19M	USD	1 Quarter
Currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.58M	USD	1 Quarter
Currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$97.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-25.43M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-16.74M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-15.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.61M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$59.97M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$71.46M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$45.80M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$15.91M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$86.90M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$87.12M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.